Analyst of TD Cowen maintained a Buy rating on Jamieson Wellness Inc, with a price target of C$48.00.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
analyst has given his Buy rating due to a combination of factors including strong execution, sustained growth, and an attractive valuation relative to fundamentals. Jamieson Wellness has delivered nine consecutive quarters of EBITDA outperformance, yet its shares trade near historical lows, creating what the analyst views as a compelling entry opportunity for a defensive, high-quality name.
China remains a major driver, with robust double-digit growth, rising repeat purchases, and margins running ahead of plan, while the company is also gaining share in Canada and maintaining momentum in the U.S. and other international markets. With a clear long-term growth runway, resilient performance across macro and geopolitical noise, and a target price implying upside from the current 10.0x NTM EBITDA multiple, the analyst believes the stock offers an appealing risk‑reward profile for investors.
In another report released on May 8, BMO Capital also maintained a Buy rating on the stock with a C$45.00 price target.
Based on the recent corporate insider activity of 44 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of JWEL in relation to earlier this year.